Topic: biotechnology

The Providence-based biotechnology company EpiVax has been working to develop T-cell based candidate vaccines for COVID-19.

News, Science & Research

Providence-based EpiVax collaborates on ongoing research for a COVID-19 vaccine

April 19, 2020 1 comment

As COVID-19 continues to spread throughout the country and the world, EpiVax, a biotechnology company based in Providence, is currently leading collaborative efforts to design a vaccine against the virus. 

New blood clot removal device proven cost-effective

Illustrations, Multimedia, News, Science & Research

New blood clot removal device proven cost-effective

January 26, 2017 2 comments

When used with medication, a new stroke treatment cost $23,203 less than treatment with medication alone.

Two Brown professors created a device that is groundbreaking in its ability to restore mobility to paralyzed primates. It contributes to research on interfaces that aid people with neurologic, cognitive or affective disorders.

Science & Research

Device allows paralyzed monkeys to walk

November 21, 2016 Comments are Disabled

A team of international scientists, including two Brown professors, has successfully developed a brain-spinal interface that helps paralyzed monkeys.

With a grant from the Swearer Center, Bella Okiddy GS and Richard Park ’16 launched Technologies Against Assault to create technology that reduces relived trauma during a shortened post-rape examination.

Science & Research, University News

Students found startup to improve rape kit testing

April 21, 2016 Comments are Disabled

Richard Park ’16 and Bella Okiddy GS are spearheading a biotech startup that aims to improve rape kit testing for victims of sexual assault.